추천 제품
양식
powder
포장
pkg of 1 × 10 mg (890809P-10mg)
제조업체/상표
Avanti Research™ - A Croda Brand 890809P
배송 상태
dry ice
저장 온도
−20°C
SMILES string
O[C@H]([C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)O[C@H](O[C@@H](O[C@@H]([C@H]([C@@H]1O)O)CO)[C@@H]1O)[C@@H]2O)[C@@H]2O
InChI
1S/C30H54O12/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22(32)39-19-21-24(34)26(36)28(38)30(41-21)42-29-27(37)25(35)23(33)20(18-31)40-29/h9-10,20-21,23-31,33-38H,2-8,11-19H2,1H3/b10-9-/t20-,21-,23-,24-,25+,26+,27-,28-,29-,30-/m1/s1
InChI key
MLVMMWOWJSIKLS-WYVBACLFSA-N
생화학적/생리학적 작용
Trehalose monooleate is derived from sugar and fatty acid moieties. It is found to possess anti-aggregation activity. Trehalose monooleate has a sustaining effect against agitation and heat stress in protein. It is considered nonhemolytic and nontoxic. Trehalose monooleate is employed in solid lipid nanoparticles for treating psoriasis.
포장
5 mL Amber Glass Screw Cap Vial (890809P-10mg)
기타 정보
For R&D use only. Not for drug, household, or other uses.
법적 정보
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
가장 최신 버전 중 하나를 선택하세요:
Smita S Kale et al.
Molecular pharmaceutics, 13(12), 4082-4093 (2016-10-12)
Protein aggregation is a major problem of therapeutic proteins because aggregation decreases their therapeutic activity and shelf life and induces immunogenicity. Stabilization against aggregation is commonly attained by addition of different excipients like sugars, surfactants, buffers, salts, amino acids, polymers
Nanomaterials for Clinical Applications: Case Studies in Nanomedicines, 17-17 (2020)
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.